Business Wire

GSMA Reveals First Details for MWC19 Barcelona

Del

The GSMA today announced the first details of MWC19 Barcelona (formerly Mobile World Congress), including keynote speakers, prominent participating companies, programmes and events. MWC19 Barcelona will take place 25-28 February 2019, with events being staged at Fira Gran Via, Fira Montjuïc and La Farga L’Hospitalet. The GSMA expects that more than 107,000 professionals from over 200 countries and territories, representing a wide range of industry sectors, will attend MWC19 Barcelona.

Under the event theme of “Intelligent Connectivity”, MWC19 Barcelona will highlight the intersection of “hyper-connectivity”, enabled by 5G and the Internet of Things (IoT), and “intelligence”, delivered by artificial intelligence (AI) and big data. In addition to the core elements of intelligent connectivity, MWC19 will explore the key topics of Content, Digital Trust, Digital Wellness and The Future.

“Underpinned by 5G and AI, intelligent connectivity is a major technological force that will shape how the world communicates well into the future,” said Michael O’Hara, Chief Marketing Officer, GSMA. “Attendees will get to experience the impact of intelligent connectivity firsthand, across the conference and exhibition and the many programmes and events taking place at MWC19 Barcelona.”

Brand Update for Flagship Event Series

The GSMA also announced that it has rebranded its flagship event series, moving from “Mobile World Congress” to “MWC”, a refresh that will be applied across all three global MWC events. The 2019 events will be referred to as MWC19 Barcelona, MWC19 Shanghai and MWC19 Los Angeles.

“This marks the first major brand update for our global event portfolio in over a decade,” commented O’Hara. “We are rapidly moving to a world where mobile will connect everyone and everything, but at the same time, we are expanding our reach beyond mobile. The new brand retains the familiar acronym, while placing less emphasis on ‘mobile’ to reflect the broadening scope of communications today.”

Execs from Citi, HTC, Vimeo, Vodafone to Keynote

The GSMA revealed the first confirmed keynote speakers for MWC19 Barcelona, with executives representing a wide range of industries including mobile, e-commerce, financial services and media and entertainment. Executives scheduled to headline the four-day Barcelona conference programme include:

  • James Forese, President, Citi
  • Blythe Masters, CEO, Digital Asset Holdings
  • Rich Williams, CEO, Groupon
  • Mats Granryd, Director General, GSMA
  • Cher Wang, Founder and CEO, HTC
  • Anjali Sud, CEO, Vimeo
  • Nick Read, Chief Executive Officer-Designate, Vodafone Group

For more information on the conference, visit www.mwcbarcelona.com/conference-programmes/.

More Than 2,400 Leading Companies to Participate at MWC19 Barcelona

MWC19 Barcelona will bring together leading players from across the mobile ecosystem, as well as adjacent industry sectors such as automotive and consumer electronics, showcasing the latest technologies, products and services. More than 2,400 companies will participate at MWC19, including major brands such as Accenture, Alibaba Cloud, ARM, AT&T, BMW, Cisco Systems, Deutsche Telekom, Ericsson, Facebook, Google, HTC, Huawei, Intel, Lenovo, LG, Mercedes-Benz, Microsoft, NTT DOCOMO, Nokia Solutions and Networks, Ooredoo, Oracle, Orange, Qualcomm Incorporated, SAP, SEAT, SK Telecom, Telefónica, Verizon, Vodafone, Xiaomi and ZTE. The show floor will also include more than 40 country and regional pavilions.

One of the perennial favourites at MWC, the GSMA Innovation City will put a spotlight on how intelligent connectivity – 5G, IoT, AI and big data – is impacting and improving the lives of citizens, enterprises and governments around the world. Visitors will experience intelligent connectivity across a range of sectors including entertainment, transportation, public services and industry, among others, with demonstrations from partners Google, Huawei, KT Corporation, Sierra Wireless and Turkcell, as well as GSMA industry and advocacy programmes. For more information, visit www.mwcbarcelona.com/exhibition/gsma-innovation-city/.

NEXTech Hall 8.0 is the destination for MWC19 attendees seeking cutting-edge technology trends, including AI, IoT, drones, robotics and virtual reality/augmented reality (AR/VR), among others. NEXTech will feature several specialised technology areas including the Drone Zone, the Graphene Pavilion and the IoT Pavilion, alongside the NEXTech Lab, an open theatre where leading industry players will present their latest innovations.

New for 2019, the GSMA introduced “Digital Planet: The Connected Experience” in Hall 8.1, an evolution of App Planet, which has been a mainstay of MWC since 2010. Digital Planet will include over 200 app, ad tech, e-commerce and marketing communication solution providers and other organisations focused on creating connected experiences and solutions that will positively impact citizens’ daily lives. Digital Turbine, Infobip, MessageBird and Toyota are among the companies that will be showcased in Digital Planet. Generalitat de Catalunya has been confirmed as the Official Sponsor of Digital Planet.

The GSMA also announced several other sponsors for MWC19 Barcelona. Husqvarna Group and SES Networks have joined as Networking Garden Sponsors, alongside returning Networking Garden Sponsors Android and Citi. Accenture also continues its support for the Women4Tech Programme as the Official Sponsor of the Women4Tech Summit. For more information on the exhibition, including exhibitors and sponsors, visit www.mwcbarcelona.com/exhibition/.

4YFN: Discover Future Innovation

4YFN is the innovation platform for MWC19 Barcelona, enabling startups, investors and companies to connect and launch new business ventures together. The three-day event, scheduled for 25-27 February 2019 at Fira Montjuïc, is expected to attract 21,000 attendees, who will have the opportunity to meet the growing global tech startup community, take inspiration from onstage talks and workshops, and develop their skills in the newly designed Discovery Area.

Over 600 companies will be exhibiting at 4YFN, including startup delegations from Colombia, France, Greece, Hungary, Japan, Jordan, South Korea and the United Kingdom, among others. Sponsors for 4YFN include Banco Sabadell, Daimler, Intel, SEAT and VISA, as well as public institutions from countries and territories including Japan, South Korea, Spain and Taiwan. For more information, visit: www.4yfn.com/event/4yfn-barcelona-2019/.

A Decade of Partner Programmes at MWC

Over the last 10 years, nearly 125 companies from across the ecosystem have delivered more than 240 sessions in the MWC Partner Programmes, providing attendees the opportunity to engage with and gain insights from the industry’s leaders. Companies confirmed to host Partner Programmes at MWC19 Barcelona include Alibaba, IBM, McCann Worldgroup, Netcracker, Taiwan Excellence, Visa, and ZTE, while Equinix and Software AG will hold Power Hour sessions. For more information, visit: www.mwcbarcelona.com/conference-programmes/partner-programmes/.

Now in Third Year, Women4Tech Expands Programme of Activities

The Women4Tech Programme is back in Barcelona with an expanded set of activities and events in its third year. Running across all four days of MWC19 Barcelona, Women4Tech is designed to address and reduce the gender gap in the mobile industry. A central element of the programme is the Women4Tech Summit, with keynote presentations and panel discussions exploring topics such as gender equality and career development; mentoring and youth education; women in communication and vertical sectors; and women as entrepreneurs and innovators.

In addition to the Summit, the Women4Tech Programme includes the Women4Tech Speed Coaching and Networking session; specialised MWC Tours; Women4Tech GLOMO awards for “Outstanding Achievement in Mobile Industry Leadership”; a Women4Tech panel on Mobile World Live TV; and Women4Tech activities at 4YFN. For more information, visit: www.mwcbarcelona.com/experiences/gsma-women4tech/.

25,000 Students and Educators to Attend 2019 YoMo

The Youth Mobile (YoMo) Festival returns to Barcelona for its third year and is expected to attract approximately 25,000 attendees, including 22,000 school group attendees – nearly 85 per cent more students than in 2018. A dedicated programme designed to inspire young people to pursue education and careers in science, technology, engineering, art/design, and math (STEAM), YoMo will offer an array of educational exhibits, live theatre shows, interactive workshops and hands-on activities, as well as educator-focused workshops, lectures and more. The 2019 edition of YoMo also includes the Enhanced Teacher Track, which focuses on digital transformation of the classroom.

YoMo will be held Tuesday, 26 February through Friday, 1 March at La Farga L’Hospitalet. Energytruck, the new mobile exhibition of Foundation Naturgy, has been confirmed as a corporate sponsor for the programme. For more information, visit: www.yomobcn.com.

The World’s Largest Carbon Neutral Tradeshow

The 2018 edition of MWC was officially certified as carbon neutral by the British Standards Institution (BSI), reiterating its position as the world’s largest carbon neutral tradeshow. In 2019, the GSMA is focused on further reducing the environmental impact and carbon footprint of the event, offsetting any outstanding emissions as necessary. It will also extend the “Donation Room” programme, through which MWC exhibitors donate used materials to Barcelona citizens at the end of the event. At the conclusion of the 2018 event, the GSMA collected 21.5 tonnes of building materials and 10 tonnes of furniture items and worked with the city councils of Barcelona and Hospitalet to provide them to more than 20 local socially responsible entities. For more information, visit www.mwcbarcelona.com/about/about-the-gsma/environmental-programme/.

Get Involved at MWC19 Barcelona

For more information on MWC19 Barcelona, including how to attend, exhibit or sponsor, visit www.mwcbarcelona.com. Follow developments and updates on MWC19 Barcelona on Twitter @GSMAEvents using #MWC19, on our LinkedIn MWC page https://www.linkedin.com/company/gsma-mobile-world-congress or on Facebook at https://www.facebook.com/mobileworldcongress/. Follow other GSMA news and activity on Twitter @GSMA.

-ENDS-

About the GSMA

The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

For the GSMA
Beau Bass
+44 79 7662 4962
beau.bass@webershandwick.com
or
GSMA Press Office
pressoffice@gsma.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma21.10.2018 10:45Pressemelding

Incyte Corporation (Nasdaq:INCY) announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment. In patients with FGFR2 translocations who were followed for at least eight months, interim study results demonstrated an overall response rate (ORR) of 40 percent, the primary endpoint, and a median progression free survival (PFS) of 9.2 months, a key secondary endpoint. These results are being presented at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany in a poster presentation on Sunday, October 21 from 12:45 p.m. CEST to 1:45 p.m. CEST (6:45 a.m. ET to 7:45 a.m. ET). (Location: Hall A3 – Poster Area Networking Hub; Abstract #756P) “We are pleased to share updated interim results from our ongoing FIGHT-202 trial

Servier and Taiho Oncology Announce Phase III LONSURF® Study Has Met Primary and Secondary Endpoints Demonstrating Prolonged Overall Survival and Progression-Free Survival in Patients with Refractory Metastatic Gastric Cancer21.10.2018 09:10Pressemelding

Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today clinical data from the pivotal Phase III TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine/tipiracil, TAS-102) versus placebo and best supportive care in patients with heavily pre-treated metastatic gastric cancer who have progressed or are intolerant to previous lines of therapy. The study met its primary endpoint of prolonged overall survival (OS) and secondary endpoint measures of progression-free survival (PFS) consistently supported the OS results, as well as continuing to demonstrate the predictable safety and tolerability profile of trifluridine/tipiracil. Data from TAGS was presented by Dr. Hendrik-Tobias Arkenau, Executive Medical Director of the Sarah Cannon Research Institute UK and an investigator for TAGS, at the ESMO 2018 Congress in Munich, Germany during an oral session (Abstract #LBA25). The study results were simultaneously published in

Phase 3 Data on Filgotinib in Biologic-Experienced Rheumatoid Arthritis to Be Presented at 2018 ACR/ARHP Annual Meeting20.10.2018 22:30Pressemelding

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents. The data, which are being presented as a late-breaking poster at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, suggest filgotinib has a potential role in addressing important unmet needs in the treatment of rheumatoid arthritis. Positive efficacy data from FINCH 2 were previously announced in September 2018. The data show statistically significant improvements in the proportion of patients achieving a range of clinical efficacy endpoints, including the proportion of patients achieving American College of Rheumatology 20 percent (ACR20, primary endpoint), 50 percent

Manchester United and True Religion Launch Denim Range19.10.2018 17:37Pressemelding

Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion

Arch Insurance Announces Strategic Leadership Changes19.10.2018 13:10Pressemelding

Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These

Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 12:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an